Analysis of the association between plasma xanthine oxidoreductase activity and atherosclerosis in the patients with metabolic diseases.
Not Applicable
Recruiting
- Conditions
- ife-style related diseases.(Type 2 diabetes,dyslipidemia,hypertension,obesity)
- Registration Number
- JPRN-UMIN000020937
- Lead Sponsor
- Toho University Sakura Medical Center Center of Diabetes,Endocrinology and Metabolism
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
Not provided
Exclusion Criteria
1.Ptients who are judged as inappropriate for inclusion by physicians. 2.Patients who can not be measured CAVI a.severe arteriosclerosis obliterans b.arterial fibrillation
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Plasma xanthine oxidoreductase activity
- Secondary Outcome Measures
Name Time Method 1)body weight,blood pressure 2)uric acid,blood glucose,HbA1c,liver function,lipid parameter(TC,TG,HDL-C,LDL-C) 3)serum creatinine,urinary albumin 4)CAVI:Cardio-ankle vascular index